1. PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND). (12th June 2019) Authors: Salles, G.; Duell, J.; González Barca, E.; Jurczak, W.; Liberati, A.M.; Nagy, Z.; Obr, A.; Gaidano, G.; Andre, M.; Kalakonda, N.; Dreyling, M.; Zinzani, P.L.; Dirnberger‐Hertweck, M.; Weirather, J.; Ambarkhane, S.; Maddocks, K. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A population‐based epidemiological study of neuromyelitis optica spectrum disorder in Hungary. (30th September 2019) Authors: Papp, V.; Iljicsov, A.; Rajda, C.; Magyari, M.; Koch‐Henriksen, N.; Petersen, T.; Jakab, G.; Deme, I.; Nagy, F.; Imre, P.; Lohner, Z.; Kovács, K.; Birkás, A. J.; Köves, Á.; Rum, G.; Nagy, Z.; Kerényi, L.; Vécsei, L.; Bencsik, K.; Jobbágy, Z. Journal: European journal of neurology Issue: Volume 27:Number 2(2020) Page Start: 308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0197 Biological Therapy and Radiosynoviorthesis in Patients with Rheumatoid Arthritis. (9th June 2015) Authors: Szentesi, M.; Nagy, Z.; Geher, P. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0082 Effects of Anti-Tnf Therapy on Circulating Oxldl-Beta2Gpi Complex Levels in Arthritis. (9th June 2015) Authors: Pusztai, A.; Végh, E.; Váncsa, A.; Bodnár, N.; Szamosi, S.; Nagy, G.; Szöllösi, I.; Csomor, P.; Lopez, L.R.; Matsuura, E.; Szücs, G.; Szántό, S.; Nagy, Z.; Shoenfeld, Y.; Szekanecz, Z. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0272 Effects of Anti-TNF Therapy on Markers of Bone Homeostasis in Rheumatoid Arthritis and Ankylosing Spondylitis. (9th June 2015) Authors: Horváth, Ά.; Pusztai, A.; Gulyás, K.; Váncsa, A.; Végh, E.; Bodnár, N.; Csomor, P.; Pethö, Z.; Juhász, B.; Szentpétery, Ά.; Szamosi, S.; Bhattoa, H.P.; Szántό, S.; Szücs, G.; Nagy, Z.; Szekanecz, Z. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0050 Effects of Anti-TNF Therapy on Markers of Angiogenesis and Vascular Pathology in Arthritis: A Comparative Approach. (9th June 2015) Authors: Balogh, E.; Végh, E.; Kerekes, G.; Váncsa, A.; Csomor, P.; Pogácsás, L.; Balázs, F.; McCormick, J.; Biniecka, M.; Szántό, S.; Szücs, G.; Nagy, Z.; Fearon, U.; Veale, D.; Szekanecz, Z. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0181 SOLUBLE VASCULAR BIOMARKERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: EFFECTS OF ONE-YEAR ANTI-TNF-Α THERAPY. (2nd June 2020) Authors: Pusztai, A.; Hamar, A.; Horváth, Á.; Végh, E.; Bodnár, N.; Kerekes, G.; Czókolyová, M.; Szamosi, S.; Bodoki, L.; Hodosi, K.; Domjan, A.; Nagy, G.; Szöllösi, I.; Lopez, L.; Matsuura, E.; Prohászka, Z.; Szántó, S.; Nagy, Z.; Shoenfeld, Y.; Szekanecz, Z. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0359 TNF ALFA THERAPY AND RADIOSYNOVIORTHESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Szentesi, M.; Nagy, Z.; Karoly Mangel, Z.; Csőre, G.; Géher, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1). (23rd June 2022) Authors: DeZern, A.; Marconi, G.; Deeren, D.; Diez Campelo, M.; Lübbert, M.; Krishnamurthy, P.; Nagy, Z.; Basak, G.; Jonášová, A.; Morozova, E.; Geissler, K.; Ofran, Y.; Kelley, H.; Volkert, A.; Baker, K.; Kang-Fortner, Q.; Hodgson, G.; Madigan, C.; Roth, D. A.; Kelly, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION. (23rd June 2022) Authors: Röth, A.; Egyed, M.; Ichikawa, S.; Ito, Y.; Kim, J. S.; Nagy, Z.; Obara, N.; Panse, J.; Schrezenmeier, H.; Sica, S.; Soret, J.; Usuki, K.; Yoon, S.-S.; Benkali, K.; Buri, M.; Lundberg, P.; Patel, H.; Shinomiya, K.; Sreckovic, S.; Nishimura, J.-I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗